| Literature DB >> 27366665 |
In O Sun1, Sung Hye Shin2, Hyun Ju Yoon1, Kwang Young Lee3.
Abstract
BACKGROUND: Paraquat (PQ) concentration-time data have been used to predict prognosis for 3 decades. The aim of this study was to find a more accurate method to predict the probability of survival.Entities:
Keywords: Creatinine; Logistic models; Paraquat; Prognosis
Year: 2016 PMID: 27366665 PMCID: PMC4919560 DOI: 10.1016/j.krcp.2016.01.003
Source DB: PubMed Journal: Kidney Res Clin Pract ISSN: 2211-9132
Summary of treatment guidelines for acute paraquat intoxication
| 1. Gastric lavage |
| 2. Dithionite urine test |
| 3. Fuller's earth, 100 g in 200-mL mannitol |
| 4. A. Antioxidant (intravenous administration) |
| Vitamin B and E |
| B. For renal preservation |
| Furosemide |
| 15% mannitol |
| 5. Emergency hemoperfusion |
| 6. Key laboratory parameters |
| Blood chemistry: blood urea nitrogen, creatinine, amylase, lipase |
| Electrolyte: Na, K, Cl |
| Arterial blood gas analysis |
| Plasma paraquat level |
Clinical and laboratory findings of the 788 patients with PQ poisoning
| Characteristics | |
|---|---|
| Age (y) | 57 ± 16 |
| Male | 507 (64) |
| Time since ingestion (h) | 6.6 ± 15.0 |
| Hemoperfusion therapy | 594 (75) |
| Serum creatinine (mg/dL) | 1.7 ± 1.3 |
| Serum alanine aminotransferase (IU/L) | 36 ± 50 |
| Serum lipase (IU/L) | 103 ± 184 |
| P | 25.0 ± 9.1 |
| HCO3 (mmol/L) | 14.8 ± 6.8 |
| Amount of PQ ingested (mL) | 151 ± 124 |
| Plasma PQ 0-h level (μg/mL) | 65 ± 115 |
| Plasma PQ 2-h level (μg/mL) | 41 ± 80 |
| Urine PQ test | |
| Negative | 30 (3.8) |
| Weakly positive | 84 (10.6) |
| Positive | 44 (5.6) |
| Strong positive | 632 (80) |
Data are presented as mean ± SD or number (%).
PQ, paraquat.
The data are available in 379 patients.
Comparison of clinical characteristics between survivors and nonsurvivors
| Survivor ( | Nonsurvivor ( | ||
|---|---|---|---|
| Age (y) | 47.0 ± 14.0 | 59.0 ± 16.0 | <0.012 |
| Male | 83 (56) | 422 (67) | 0.233 |
| Time since ingestion (h) | 8.7 ± 17.2 | 6.1 ± 14.4 | 0.094 |
| Hemoperfusion therapy | 141 (95) | 453 (71) | <0.015 |
| Serum creatinine (mg/dL) | 1.0 ± 0.9 | 1.9 ± 1.3 | <0.012 |
| Serum alanine aminotransferase (IU/L) | 32.0 ± 34.0 | 37.0 ± 53.0 | 0.230 |
| Serum lipase (IU/L) | 46.0 ± 38.0 | 115.0 ± 200.0 | <0.010 |
| P | 30.0 ± 7.0 | 23.0 ± 9.0 | <0.011 |
| HCO3 (mmol/L) | 19.0 ± 14.0 | 13.0 ± 7.0 | <0.012 |
| Amount of PQ ingested (mL) | 34.0 ± 22.0 | 178.0 ± 122.0 | <0.014 |
| Plasma PQ 0-h level (μg/mL) | 0.4 ± 0.7 | 80.3 ± 123.1 | <0.010 |
| Plasma PQ 2-h level (μg/mL) | 0.2 ± 0.3 | 58.9 ± 102.1 | <0.013 |
| Urine PQ test | <0.010 | ||
| Negative | 26 (17) | 4 (1) | |
| Weakly positive | 69 (46) | 15 (2) | |
| Positive | 30 (20) | 14 (2) | |
| Strong positive | 24 (16) | 606 (95) |
Data are presented as mean ± SD or number (%).
NS, not significant; PQ, paraquat.
The data are available in 82 patients.
The data are available in 297 patients.
Figure 1Comparison of receiver operating characteristic analysis of models using logistic regression. The sensitivity and specificity of Models 2 and 3 are better than those of Model 1. The curve of Model 2 is very close to that of Model 3, which is not shown in this figure.
Univariate logistic regression analysis
| Variables | Relative risk | 95% Confidence interval | ||
|---|---|---|---|---|
| Age (y) | 1.046 | 1.033 | 1.058 | <0.011 |
| Male | 1.546 | 1.076 | 2.222 | 0.018 |
| ln(time) | 0.820 | 0.515 | 1.307 | 0.405 |
| HP | 0.139 | 0.067 | 0.290 | <0.012 |
| ln(Cr) | 20.132 | 11.374 | 35.639 | <0.010 |
| Serum ALT (IU/L) | 1.004 | 0.998 | 1.010 | 0.204 |
| Serum lipase (IU/L) | 1.010 | 1.009 | 1.023 | <0.011 |
| P | 0.912 | 0.898 | 0.939 | <0.012 |
| HCO3 (mmol/L) | 0.821 | 0.804 | 0.866 | <0.013 |
| ln(PQ) | 2.648 | 2.271 | 3.087 | <0.011 |
ALT, alanine aminotransferase; Cr, creatinine; HP, hemoperfusion; PQ, paraquat.
Multivariate logistic regression analysis
| Variable | B | Relative risk | 95% Confidence interval | |
|---|---|---|---|---|
| Age (y) | 0.032 | 1.271 | 1.012–1.053 | 0.010 |
| ln(Cr) | 1.551 | 4.721 | 2.553–8.715 | <0.001 |
| ln(time) | 0.391 | 1.478 | 1.048–2.085 | 0.032 |
| ln(PQ) | 1.076 | 2.932 | 2.406–3.573 | <0.001 |
Cr, creatinine; PQ, paraquat.
Analysis of ROC curve
| Sensitivity (95% CI) | Specificity (95% CI) | PPV | NPV | AUC (95% CI) | ||
|---|---|---|---|---|---|---|
| Model 1 | 0.861 (0.831–0.887) | 0.966 (0.923–0.989) | 0.991 | 0.618 | 0.957 (0.941–0.670) | Models 2, 3 > Model 1 |
| Model 2 | 0.865 (0.836–0.891) | 0.987 (0.952–0.998) | 0.996 | 0.631 | 0.972 (0.958–0.982) | |
| Model 3 | 0.887 (0.860–0.911) | 0.980 (0.942–0.996) | 0.995 | 0.670 | 0.974 (0.960–0.984) |
AUC, area under the curve; CI, confidence interval; NPV, negative predictive value; PPV, positive predictive value; ROC, receiver operating characteristic.